Authors: CALVO G

Citation: G. Calvo, COMMENTS ON THE NOTE FOR GUIDANCE ON BIOAVAILABILITY AND BIOEQUIVALENCE IN THE EUROPEAN-UNION, Methods and findings in experimental and clinical pharmacology, 20, 1998, pp. 11-11

Authors: CALVO G MORROS R MATEU S TORRES F TORRENT J JANE F

Citation: G. Calvo et al., ADVERSE DRUG-REACTIONS IN HIV-POSITIVE HOSPITALIZED-PATIENTS - A ONE-YEAR DRUG SURVEILLANCE PROGRAM - STUDY DESIGN, Methods and findings in experimental and clinical pharmacology, 18, 1996, pp. 27-28

Authors: FRONTERA G MATEU S BARRIO JL CLOPES A FANJUL L TORRES F MORROS R CALVO G JANE F

Citation: G. Frontera et al., UTILIZATION OF 3RD GENERATION CEPHALOSPORINS WITHOUT ANTIPSEUDOMONAL ACTIVITY IN A TEACHING HOSPITAL, Methods and findings in experimental and clinical pharmacology, 18, 1996, pp. 81-81

Authors: CALVO G MORROS R MATEU S FANJUL L TORRES F JANE F

Citation: G. Calvo et al., PATIENT CHARACTERISTICS AND DRUG PRESCRIPTION IN A HIV-POSITIVE PATIENTS MEDICAL WARD, Methods and findings in experimental and clinical pharmacology, 18, 1996, pp. 82-82

Authors: ALONSO M MATEU S FANJUL L CALVO G

Citation: M. Alonso et al., INTEGRATION OF CLINICAL PHARMACOLOGISTS IN AN ASSISTENCIAL MEDICAL TEAM - HOW IT INFLUENCES OVER THE QUESTIONS RECEIVED BY A DRUG INFORMATION UNIT, Methods and findings in experimental and clinical pharmacology, 18, 1996, pp. 82-82

Authors: MATIASGUIU J ALVAREZSABIN J FERRO J CALVO G GALVE E GOMEZ MD IZQUIERDO I MORROS R NAVAS C PAREDES I TORRENT J TORRES F

Citation: J. Matiasguiu et al., TRIFLUSAL ASPIRIN CEREBRAL INFARCTION PREVENTION (TACIP) STUDY - ONGOING CLINICAL-TRIAL, Methods and findings in experimental and clinical pharmacology, 18, 1996, pp. 92-92